Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156448 | SCV000206167 | uncertain significance | not specified | 2014-04-04 | criteria provided, single submitter | clinical testing | The Ala43Ser variant in TNNI3 has not been previously reported in individuals wi th cardiomyopathy and data from large population studies is insufficient to asse ss its frequency. Alanine (Ala) at position 43 is highly conserved in evolution; however, this variant was predicted to be benign using a computational tool cli nically validated by our laboratory. This tool's benign prediction is estimated to be correct 89% of the time (Jordan 2011). Additional information is needed to fully assess the clinical significance of the Ala43Ser variant. |